From The Cancer Chronicles #32-#33
© June 1996 by Ralph W. Moss, Ph.D.

Disillusionment with chemotherapy is mounting within the medical profession. In a lecture last fall, the doyen of French oncologists, Lucien Israel, MD, said, "One mustn't count blindly on chemotherapy to destroy cancer cells. These sick cells, when they are not eradicated by drugs, can become more and more aggressive and more and more difficult to treat" (quoted in La Presse of Montréal,10/26/95).

Dr. Israel has spent nearly 60 years in the cancer field. At one time he was an ardent enthusiast for chemical treatments but has gradually realized that a large number of cancers simply develop a resistance to such drugs. And such resistance is attributable to the "stress toxique" generated by the treatment itself.

"These cells develop an instinct for survival," he told an audience at the Jewish General Hospital in Montréal. "The chemotherapeutic approach is far from optimal."

He suggested that oncologists revise their approach. Instead of trying to kill every last cancer cell, he suggested that they try to guide them towards normality.

Similar points were made in April by three eminent scientists in an editorial in the Journal of Clinical Oncology, the official journal of the American Society of Clinical Oncology. The three are Howard Schipper of the University of Manitoba; C.R. Goh, of the Institute of Molecular and Cell Biology in Singapore, and T. L. Wang, of the National University Hospital in Singapore.

In a tightly reasoned, six-page manifesto entitled "Shifting the Cancer Paradigm: Must We Kill to Cure?" the three brilliantly lay the groundwork for an entirely new paradigm in cancer treatment. Their wording is cautious and conciliatory but the message remains revolutionary. Such changes would involve a scaling down of the chemotherapy enterprise.

Finally, Dr. Michael Sporn, a cancer expert at Dartmouth Medical School, wrote in the Lancet in mid-May 1996 that the 25 - year "war on cancer'' has failed. The reason is "an obsession with the concept of 'cure' of advanced disease, as opposed to the prevention of early disease.'' Cancer cells become so varied that it is nearly impossible for any combination of treatments to kill them all. And even so-called "early diagnosis is often late diagnosis...."

"Reductionist molecular biology," he said, "can only proceed so far with its brilliant analysis of all the bits and pieces that comprise the organism. Carcinoma is not a disease of an individual cell.'' Rather it is an aberrancy in normal cell make-up. Therefore, Sporn advocated chemoprevention to wipe out the abnormal cells before they develop into aggressive malignancies.

Ralph W. Moss, Ph.D. is director of the The Moss Reports for cancer patients. Dr. Moss is the author of eleven books and three documentaries on cancer-related topics. He is or has been an advisor on alternative cancer treatments to the National Institutes of Health, the National Cancer Institute, the American Urological Association, Columbia University, the University of Texas, the Susan G. Komen Foundation and the German Society of Oncology. He wrote the first article on alternative medicine for the Encyclopedia Britannica yearbook. He is listed in Marquis Who's Who in America, Who's Who in the World, Who's Who in the East, and Who's Who in Entertainment (as a film documentarian). This Web site does not advocate any particular treatment for cancer. We urge you to always seek competent medical advice for all health problems, especially cancer. Before consulting our site please read our full Disclaimer statement.

home - moss reports - books - - contact - order - news
members - chronicles - faq - free email newsletter